Sp1 Upregulates Survivin Expression in Adenocarcinoma of Lung Cell Line A549

Yuqing Chen(Peking University), Changjie Chen(Bengbu Medical College), Chengling Zhao(Bengbu Medical College), Wěi Li(Shougang (China)), Yan Li(Beijing Tongren Hospital), Xiaojing Wang(First Affiliated Hospital of Bengbu Medical College), Hailong Zhang(Baotou Central Hospital), Zhenhuan Wang(Bengbu Medical College)
The Anatomical Record
March 23, 2011
10.1002/ar.21378
Cited by 30

Related Papers

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
HIF-1α pathway: role, regulation and intervention for cancer therapy
|Acta Pharmaceutica Sinica B|2015|1.9k
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
|The Lancet|2022|664
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
|Journal of the American College of Cardiology|2019|494
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients
|Science Translational Medicine|2016|416